Report : Europe DNA Extraction, Isolation, and Purification Market Forecast to 2030 - Regional Analysis - by Type (Kits, Instruments, and Reagents), Method (Chemical Method and Physical Method), Sample Type (Blood, Body Fluids, and Others), Source (Genomic DNA and Microbial DNA), Application [PCR Test, Next Generation Sequencing (NGS), Microarray, and Others], and End User (Hospitals, Diagnostic Centers and Research Laboratories, Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, and Others)
At 8.7% CAGR, the Europe DNA Extraction, Isolation, and Purification Market is Speculated to be Worth US$ 1,303.96 Million by 2030, Says Business Market Insights
According to Business Market Insights research, the Europe DNA extraction, isolation, and purification market was valued at US$ 667.31 million in 2022 and is expected to reach US$ 1,303.96 million by 2030, registering a CAGR of 8.7% from 2022 to 2030. New product launches and approvals and emerging applications of extracted and purified DNA are among the critical factors attributed to the Europe DNA extraction, isolation, and purification market expansion.
The biotechnology industry is developing significantly due to the increasing demand for technologically advanced products. This, in turn, results in a rise in the number of new product developments, launches, and approvals. Additionally, major market players engage in R&D activities to ensure the innovation and development of efficient products. A few of the recent product launches and developments in the DNA extraction, isolation, and purification market are mentioned below.
CD Bioparticles is a leading manufacturer and supplier of various products in application areas such as in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. In August 2023, the company announced the launch of its new line of DNA extraction and purification kits made for the quick and accurate isolation of DNA, including cell-free DNA (cfDNA), genomic DNA, plasmid DNA, tissue DNA, mitochondrial DNA, and PCR In March 2023, BioEcho Life Sciences announced the launch of EchoLUTION FFPE DNA Kit that offers an innovative way to extract DNA from Formalin-Fixed Paraffin-Embedded (FFPE) samples. In April 2022, Purigen Biosystems, Inc., one of the leading providers of next-generation technologies, announced the launch of Ionic Cells to Pure DNA Kit. The kit has been optimized to allow the users of Ionic Purification Systems to extract higher-quality DNA from white blood cells (WBCs), peripheral blood mononuclear cells (PBMCs), and cultured or sorted cells. Thus, an increase in product developments, and launches is likely to create ample opportunities for the growth of the DNA extraction, isolation, and purification market in the coming years.
On the contrary, high cost of process and need for highly skilled workforces hampers the growth Europe DNA extraction, isolation, and purification market.
Based on type, the Europe DNA extraction, isolation, and purification market is categorized into kits, instrument, and reagent. The kits segment held 63.4% share of the Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 422.89 million. It is projected to garner US$ 845.95 million by 2030 to expand at 9.1% CAGR during 2022-2030.
In terms of method, the Europe DNA extraction, isolation, and purification market is bifurcated into chemical method and physical method. The chemical method segment held 82.8% share of the Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 552.29 million. It is projected to garner US$ 1,080.97 million by 2030 to expand at 8.8% CAGR during 2022-2030. The chemical method is further subsegmented into phenol chloroform, silica gel, proteinase, and others. The physical method is further subsegmented into magnetic bead and paper.
By sample type, the Europe DNA extraction, isolation, and purification market is segmented into blood, body fluid, and others. The blood segment held 53.5% share of Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 356.70 million. It is projected to garner US$ 703.92 million by 2030 to expand at 8.9% CAGR during 2022-2030.
By source, the Europe DNA extraction, isolation, and purification market is segmented into genomic and microbial. The genomic segment held 78.3% share of Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 522.74 million. It is projected to garner US$ 1,027.09 million by 2030 to expand at 8.8% CAGR during 2022-2030. The microbial segment is further subsegmented into bacteria and virus.
Based on application, the Europe DNA extraction, isolation, and purification market is categorized into PCR test, next generation sequencing, micro array, and others. The next generation sequencing segment held 40.4% share of the Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 269.50 million. It is projected to garner US$ 532.91 million by 2030 to expand at 8.9% CAGR during 2022-2030. The PCR test segment is further subsegmented into qPCR, multiplex PCR, 16S PCR, and others.
By end user, the Europe DNA extraction, isolation, and purification market is segmented into diagnostic center and research laboratories, pharmaceutical and biopharmaceutical companies, CROs, and others. The diagnostic center and research laboratories segment held 48.9% share of Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 326.29 million. It is projected to garner US$ 639.97 million by 2030 to expand at 8.8% CAGR during 2022-2030.
Based on country, the Europe DNA extraction, isolation, and purification market is categorized into the UK, Germany, France, Italy, Spain, Benelux, Austria, and the Rest of Europe. The UK held 21.0% share of Europe DNA extraction, isolation, and purification market in 2022, amassing US$ 140.27 million. It is projected to garner US$ 284.91 million by 2030 to expand at 9.3% CAGR during 2022-2030.
Key players operating in the Europe DNA extraction, isolation, and purification market are Bio-Rad Laboratories Inc, Danaher Corp, GE HealthCare Technologies Inc, F. Hoffmann-La Roche Ltd, Agilent Technologies Inc, Qiagen NV, Merck KGaA, Illumina Inc, Takara Bio Inc, Thermo Fisher Scientific Inc, and Molzym GmbH & Co KG, among others.
- In Aug 2023, Thermo Fisher Scientific launched a new chromosomal microarray designed to improve cytogenetic research lab productivity, efficiency and profitability with an industry-leading two-day turnaround time. Providing insights on chromosomal variants for a wide range of prenatal, postnatal and oncology research applications, the Applied Biosystems CytoScan HD Accel array analyzes the whole human genome and provides improved coverage in more than 5,000 critical genome regions.
- In Jul 2023, QIAGEN launched of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com